First Time Loading...

STAAR Surgical Co
NASDAQ:STAA

Watchlist Manager
STAAR Surgical Co Logo
STAAR Surgical Co
NASDAQ:STAA
Watchlist
Price: 46.89 USD -1.94% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. [ Read More ]

The intrinsic value of one STAA stock under the Base Case scenario is 21.88 USD. Compared to the current market price of 46.89 USD, STAAR Surgical Co is Overvalued by 53%.

Key Points:
STAA Intrinsic Value
Base Case
21.88 USD
Overvaluation 53%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
STAAR Surgical Co

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling STAA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
STAAR Surgical Co

Provide an overview of the primary business activities
of STAAR Surgical Co.

What unique competitive advantages
does STAAR Surgical Co hold over its rivals?

What risks and challenges
does STAAR Surgical Co face in the near future?

Has there been any significant insider trading activity
in STAAR Surgical Co recently?

Summarize the latest earnings call
of STAAR Surgical Co.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for STAAR Surgical Co.

Provide P/S
for STAAR Surgical Co.

Provide P/E
for STAAR Surgical Co.

Provide P/OCF
for STAAR Surgical Co.

Provide P/FCFE
for STAAR Surgical Co.

Provide P/B
for STAAR Surgical Co.

Provide EV/S
for STAAR Surgical Co.

Provide EV/GP
for STAAR Surgical Co.

Provide EV/EBITDA
for STAAR Surgical Co.

Provide EV/EBIT
for STAAR Surgical Co.

Provide EV/OCF
for STAAR Surgical Co.

Provide EV/FCFF
for STAAR Surgical Co.

Provide EV/IC
for STAAR Surgical Co.

Show me price targets
for STAAR Surgical Co made by professional analysts.

What are the Revenue projections
for STAAR Surgical Co?

How accurate were the past Revenue estimates
for STAAR Surgical Co?

What are the Net Income projections
for STAAR Surgical Co?

How accurate were the past Net Income estimates
for STAAR Surgical Co?

What are the EPS projections
for STAAR Surgical Co?

How accurate were the past EPS estimates
for STAAR Surgical Co?

What are the EBIT projections
for STAAR Surgical Co?

How accurate were the past EBIT estimates
for STAAR Surgical Co?

Compare the revenue forecasts
for STAAR Surgical Co with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of STAAR Surgical Co and its key competitors using the latest financial data.

Compare historical revenue growth rates
of STAAR Surgical Co against its competitors.

Analyze the profit margins
(gross, operating, and net) of STAAR Surgical Co compared to its peers.

Compare the P/E ratios
of STAAR Surgical Co against its peers.

Discuss the investment returns and shareholder value creation
comparing STAAR Surgical Co with its peers.

Analyze the financial leverage
of STAAR Surgical Co compared to its main competitors.

Show all profitability ratios
for STAAR Surgical Co.

Provide ROE
for STAAR Surgical Co.

Provide ROA
for STAAR Surgical Co.

Provide ROIC
for STAAR Surgical Co.

Provide ROCE
for STAAR Surgical Co.

Provide Gross Margin
for STAAR Surgical Co.

Provide Operating Margin
for STAAR Surgical Co.

Provide Net Margin
for STAAR Surgical Co.

Provide FCF Margin
for STAAR Surgical Co.

Show all solvency ratios
for STAAR Surgical Co.

Provide D/E Ratio
for STAAR Surgical Co.

Provide D/A Ratio
for STAAR Surgical Co.

Provide Interest Coverage Ratio
for STAAR Surgical Co.

Provide Altman Z-Score Ratio
for STAAR Surgical Co.

Provide Quick Ratio
for STAAR Surgical Co.

Provide Current Ratio
for STAAR Surgical Co.

Provide Cash Ratio
for STAAR Surgical Co.

What is the historical Revenue growth
over the last 5 years for STAAR Surgical Co?

What is the historical Net Income growth
over the last 5 years for STAAR Surgical Co?

What is the current Free Cash Flow
of STAAR Surgical Co?

Discuss the annual earnings per share (EPS)
trend over the past five years for STAAR Surgical Co.

Financials

Balance Sheet Decomposition
STAAR Surgical Co

Current Assets 365.3m
Cash & Short-Term Investments 220.7m
Receivables 98m
Other Current Assets 46.6m
Non-Current Assets 123.4m
Long-Term Investments 11.7m
PP&E 101.4m
Intangibles 1.8m
Other Non-Current Assets 8.5m
Current Liabilities 65m
Accounts Payable 13.6m
Accrued Liabilities 24.4m
Other Current Liabilities 27.1m
Non-Current Liabilities 37.7m
Long-Term Debt 42k
Other Non-Current Liabilities 37.7m
Efficiency

Earnings Waterfall
STAAR Surgical Co

Revenue
322.4m USD
Cost of Revenue
-69.8m USD
Gross Profit
252.7m USD
Operating Expenses
-224.6m USD
Operating Income
28.1m USD
Other Expenses
-6.8m USD
Net Income
21.3m USD

Free Cash Flow Analysis
STAAR Surgical Co

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

STAA Profitability Score
Profitability Due Diligence

STAAR Surgical Co's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive 3-Year Average ROIC
Negative Free Cash Flow
59/100
Profitability
Score

STAAR Surgical Co's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

STAA Solvency Score
Solvency Due Diligence

STAAR Surgical Co's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

STAAR Surgical Co's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

STAA Price Targets Summary
STAAR Surgical Co

Wall Street analysts forecast STAA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STAA is 49.24 USD with a low forecast of 33.33 USD and a high forecast of 63 USD.

Lowest
Price Target
33.33 USD
29% Downside
Average
Price Target
49.24 USD
5% Upside
Highest
Price Target
63 USD
34% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

STAA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

STAA Price
STAAR Surgical Co

1M 1M
+30%
6M 6M
+23%
1Y 1Y
-31%
3Y 3Y
-65%
5Y 5Y
+43%
10Y 10Y
+150%
Annual Price Range
46.89
52w Low
27.67
52w High
72.82
Price Metrics
Average Annual Return 27.46%
Standard Deviation of Annual Returns 76.09%
Max Drawdown -83%
Shares Statistics
Market Capitalization 2.3B USD
Shares Outstanding 48 865 900
Percentage of Shares Shorted 22.31%

STAA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

STAAR Surgical Co Logo
STAAR Surgical Co

Country

United States of America

Industry

Health Care

Market Cap

2.3B USD

Dividend Yield

0%

Description

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company is headquartered in Lake Forest, California and currently employs 692 full-time employees. The company is a manufacturer of lenses used worldwide in corrective or refractive surgery. The company sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux and Italy. Its manufacturing facility in Monrovia, California, makes the Visian implantable Collamer lens product family, including the EVO Visian ICL, preloaded silicone cataract intraocular lenses and injector systems. Its manufacturing facility in Brugg, Switzerland, operates an administrative, distribution and operational through its subsidiary, STAAR Surgical AG. The company operates administrative and distribution facilities in Japan through its subsidiary, STAAR Japan Inc.

Contact

CALIFORNIA
Lake Forest
25651 Atlantic Ocean Drive
+16263037902.0
http://staar.com/

IPO

1983-07-08

Employees

692

Officers

President, CEO & Chairman
Mr. Thomas G. Frinzi
Chief Financial Officer
Mr. Patrick F. Williams
Chief Technology Officer
Dr. Keith Holliday Ph.D.
Senior Vice President of Commercial Operations - North America & APAC
Mr. James Francese
Chief Medical Officer
Dr. Scott D. Barnes M.D.
Chief Operating Officer
Mr. Warren Foust
Show More
Vice President of Investor Relations & Corporate Development
Mr. Brian Moore
Chief Legal Officer & Corporate Secretary
Mr. Samuel J. Gesten
Chief Clinical, Regulatory & Medical Affairs Officer
Dr. Magda Michna Ph.D.
Senior Vice President of Operations
Mr. Robert Studholme
Show Less

See Also

Discover More
What is the Intrinsic Value of one STAA stock?

The intrinsic value of one STAA stock under the Base Case scenario is 21.88 USD.

Is STAA stock undervalued or overvalued?

Compared to the current market price of 46.89 USD, STAAR Surgical Co is Overvalued by 53%.